Ocular Pharmacology and Drug Delivery

Ocular Pharmacology and Drug Delivery examines the discovery, development, administration, safety, and effectiveness of therapies for eye disease. The session includes conventional and novel drugs, biologics, sustained-release systems, targeted delivery, intraocular therapies, pharmacokinetics, toxicity, and innovative platforms designed to improve therapeutic effectiveness.

Abstract Scope and Participation

Submissions may cover drug discovery, ocular therapeutics, pharmacology, formulation, biologics, delivery systems, safety, pharmacokinetics, clinical trials, and treatment outcomes. Pharmacologists, ophthalmologists, pharmaceutical scientists, researchers, clinicians, biomedical engineers, and industry professionals are invited to participate.